DK612889D0 - Enzym og fremgangsmaade til fremstilling deraf - Google Patents

Enzym og fremgangsmaade til fremstilling deraf

Info

Publication number
DK612889D0
DK612889D0 DK612889A DK612889A DK612889D0 DK 612889 D0 DK612889 D0 DK 612889D0 DK 612889 A DK612889 A DK 612889A DK 612889 A DK612889 A DK 612889A DK 612889 D0 DK612889 D0 DK 612889D0
Authority
DK
Denmark
Prior art keywords
retroviral
proteins
producing
protease
genes
Prior art date
Application number
DK612889A
Other languages
English (en)
Other versions
DK612889A (da
Inventor
Atsusi Saito
Hideo Shinagawa
Atsuo Nakata
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1088411A external-priority patent/JP2852431B2/ja
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of DK612889D0 publication Critical patent/DK612889D0/da
Publication of DK612889A publication Critical patent/DK612889A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK612889A 1988-12-07 1989-12-05 Enzym og fremgangsmaade til fremstilling deraf DK612889A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30942788 1988-12-07
JP1088411A JP2852431B2 (ja) 1988-12-07 1989-04-06 レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法

Publications (2)

Publication Number Publication Date
DK612889D0 true DK612889D0 (da) 1989-12-05
DK612889A DK612889A (da) 1990-06-08

Family

ID=26429797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK612889A DK612889A (da) 1988-12-07 1989-12-05 Enzym og fremgangsmaade til fremstilling deraf

Country Status (9)

Country Link
EP (1) EP0372904B1 (da)
AT (1) ATE112318T1 (da)
AU (1) AU643942B2 (da)
CA (1) CA2004646C (da)
DE (1) DE68918563T2 (da)
DK (1) DK612889A (da)
HU (1) HU209835B (da)
MY (1) MY104975A (da)
NZ (1) NZ231593A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0485611B1 (en) * 1990-05-28 1999-03-17 The Research Foundation For Microbial Diseases Of Osaka University Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
WO1992011028A1 (en) * 1990-12-19 1992-07-09 Epitope, Inc. Hiv reverse transcriptase vaccine
EP0555797A1 (en) * 1992-02-10 1993-08-18 Becton, Dickinson and Company General buffer for restriction endonucleases
EP0805873B1 (en) * 1995-01-27 1999-09-01 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Methods for sensitive detection of reverse transcriptase
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
DE69739645D1 (de) * 1996-01-29 2009-12-17 Monogram Biosciences Inc Verfahren zur Bestimmung antiviraler Wirkstoff Suszeptibilität und Resistenz sowie antivirales Wirkstoff-Screening

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503356A (ja) * 1986-05-20 1988-12-08 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク ヒトｔ細胞リンパ球向性ウイルス（ｈｔｌｖ‐３）逆転写酵素の発現及びその使用

Also Published As

Publication number Publication date
AU4590889A (en) 1990-08-02
DE68918563T2 (de) 1995-02-23
DE68918563D1 (de) 1994-11-03
EP0372904B1 (en) 1994-09-28
EP0372904A3 (en) 1991-09-25
ATE112318T1 (de) 1994-10-15
HU896176D0 (en) 1990-02-28
HU209835B (en) 1994-11-28
CA2004646C (en) 1999-10-05
AU643942B2 (en) 1993-12-02
DK612889A (da) 1990-06-08
MY104975A (en) 1994-07-30
HUT54412A (en) 1991-02-28
CA2004646A1 (en) 1990-06-07
EP0372904A2 (en) 1990-06-13
NZ231593A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
FI881185A0 (fi) Human mangan-superoxiddismutas (hmn-sod).
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DK0495896T3 (da) Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DE69941059D1 (de) Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
ES2058566T3 (es) Sondas de hibridacion para detectar las cepas de neisseria.
DE69132681D1 (de) Klonierung und Expression von Borrelia Lipoproteinen
FI863188A (fi) Kombinationsfoerfaranden foer producering av serinproteas-inhibitorer och foer dessa anvaendbara dna-sekvenser.
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
DK612889D0 (da) Enzym og fremgangsmaade til fremstilling deraf
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
LU90781I2 (fr) Fasturtec -rasburicase
DK587488D0 (da) Fibroblast-vaekstfaktor, nucleotidsekvens kodende derfor, praeparat indeholdende faktoren og fremgangsmaade til fremstilling deraf
HUP9801681A2 (hu) Mutáns proteinek
DE3850261D1 (de) Gen des hüllproteins des gurkenmosaikvirus.
Saito et al. Protease, reverse transcriptase and endonuclease of HIV-1 and RSV method for producing these enzymes
HUP9802915A2 (hu) Új sztafilokinázszármazékok
TH9629EX (th) โพรเทเอส, รีเวอร์ส แทรนส์คริพเทส และเอนโดนิวคลี เอสของ ของเรโทรไวรัส และวิธีการสำหรับผลิตเอนไซม์เหล่า นี้
TH21549A (th) ลำดับเบสของยีนโปรตีนหุ้มห่อของไวรัสโรคใบลายและผิดรูปของมะละกอ
TH9629A (da)

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment